CLOV Stock: Why One Analyst Is Now Souring on Clover Health

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

JPMorgan told clients to "underweight" Clover Health after the Medicare management firm lowered most guidance metrics. It knocked the CLOV stock price target down to $9 a share.

The post CLOV Stock: Why One Analyst Is Now Souring on Clover Health appeared first on InvestorPlace.

• Stock Prodigy Who Found NIO at $2… Says Buy THIS Now
• It doesn’t matter if you have $500 in savings or $5 million. Do this now.